Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Update Il y a 4 ans
Reference: NCT00429559

Woman Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Topotecan and gemcitabine are drugs globally registered for recurrent ovarian carcinoma. This trial will determine the maximum tolerated dose and the efficacy of this combination administered weekly in patients with platinum -resistant ovarian cancer.


Inclusion criteria

  • Ovarian Cancer

Links